Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar

Update Il y a 4 ans
Reference: NCT00371995

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Miltefosine and liposomal amphotericin B (AmBisome) are approved drugs for visceral leishmaniasis. In this study both drugs will be given in a sequential manner. AmBisome will be given on day 1, followed by Miltefosine for 14 days. Final Cure will be evaluated at six months.


Inclusion criteria

  • Visceral leishmaniasis

Links